Opheim O. Loss of hearing following the syndrome of Van der Hoeve-de Kleyn. Acta Otolaryngol. 1968;65(3):337–44.

Article  CAS  PubMed  Google Scholar 

Weiss NM. Rare Diseases of the Middle Ear and Lateral Skull Base. Laryngorhinootologie. 2021;100(S 01):S1-S30.

Claeys L, Storoni S, Eekhoff M, et al. Collagen transport and related pathways in Osteogenesis Imperfecta. Hum Genet. 2021;140(8):1121–41.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Steiner RD, Basel D. COL1A1/2 Osteogenesis Imperfecta. In: Adam MP, Everman DB, Mirzaa GM, et al., editors. GeneReviews((R)). Seattle; 1993.

Whyte MP, Aronson J, McAlister WH, et al. Coalescing expansile skeletal disease: delineation of an extraordinary osteopathy involving the IFITM5 mutation of osteogenesis imperfecta type V. Bone. 2021;145: 115835.

Article  CAS  PubMed  Google Scholar 

Tauer JT, Abdullah S, Rauch F. Effect of Anti-TGF-beta treatment in a mouse model of severe osteogenesis imperfecta. J Bone Miner Res. 2019;34(2):207–14.

Article  CAS  PubMed  Google Scholar 

Etich J, Rehberg M, Eckes B, Sengle G, Semler O, Zaucke F. Signaling pathways affected by mutations causing osteogenesis imperfecta. Cell Signal. 2020;76: 109789.

Article  CAS  PubMed  Google Scholar 

Swinnen FK, De Leenheer EM, Coucke PJ, Cremers CW, Dhooge IJ. Audiometric, surgical, and genetic findings in 15 ears of patients with osteogenesis imperfecta. Laryngoscope. 2009;119(6):1171–9.

Article  PubMed  Google Scholar 

Kawai S, Yoshitomi H, Sunaga J, et al. In vitro bone-like nodules generated from patient-derived iPSCs recapitulate pathological bone phenotypes. Nat Biomed Eng. 2019;3(7):558–70.

Article  PubMed  Google Scholar 

Swinnen FK, De Leenheer EM, Goemaere S, Cremers CW, Coucke PJ, Dhooge IJ. Association between bone mineral density and hearing loss in osteogenesis imperfecta. Laryngoscope. 2012;122(2):401–8.

Article  PubMed  Google Scholar 

Jung H, Rim YA, Park N, Nam Y, Ju JH. Restoration of osteogenesis by CRISPR/Cas9 genome editing of the mutated COL1A1 gene in osteogenesis imperfecta. J Clin Med. 2021;10(14):3141.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rauch F, Geng Y, Lamplugh L, et al. Crispr-Cas9 engineered osteogenesis imperfecta type V leads to severe skeletal deformities and perinatal lethality in mice. Bone. 2018;107:131–42.

Article  CAS  PubMed  Google Scholar 

Ma S, Saleem A, Li X, Lu WJ, Jiang H. Generation of a COL1A2 homozygous knockout stem cell line via CRISPR/Cas9 system. Stem Cell Res. 2022;59: 102652.

Article  CAS  PubMed  Google Scholar 

Li H, Handsaker B, Wysoker A, et al. The sequence alignment/map format and SAMtools. Bioinformatics. 2009;25(16):2078–9.

Article  PubMed  PubMed Central  Google Scholar 

Qin F, Luo X, Cai G, Xiao F. Shall genomic correlation structure be considered in copy number variants detection? Brief Bioinform. 2021;22(6):bbab15.

Article  Google Scholar 

Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861–72.

Article  CAS  PubMed  Google Scholar 

Li S, He C, Feng Q, et al. Establishment of two iPSC lines from healthy donor with heterozygous mutation in the SLC26A4 gene. Stem Cell Res. 2022;64: 102916.

Article  CAS  PubMed  Google Scholar 

Malik N, Rao MS. A review of the methods for human iPSC derivation. Methods Mol Biol (Clifton, NJ). 2013;997:23–33.

Article  CAS  Google Scholar 

Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663–76.

Article  CAS  PubMed  Google Scholar 

Xi L, Zhang H, Zhang ZL. Genotypic and phenotypic characteristics of 29 patients with rare types of osteogenesis imperfecta: average 5 years of follow-up. Front Genet. 2021;12: 622078.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Giacalone JC, Sharma TP, Burnight ER, et al. CRISPR-Cas9-based genome editing of human induced pluripotent stem cells. Curr Protoc Stem Cell Biol. 2018;44(5B71):5B722.

Google Scholar 

Brenner RE, Vetter U, Nerlich A, Worsdorfer O, Teller WM, Muller PK. Osteogenesis imperfecta: insufficient collagen synthesis in early childhood as evidenced by analysis of compact bone and fibroblast cultures. Eur J Clin Invest. 1989;19(2):159–66.

Article  CAS  PubMed  Google Scholar 

Kuurila K, Kaitila I, Johansson R, Grenman R. Hearing loss in Finnish adults with osteogenesis imperfecta: a nationwide survey. Ann Otol Rhinol Laryngol. 2002;111(10):939–46.

Article  PubMed  Google Scholar 

Barsh GS, Byers PH. Reduced secretion of structurally abnormal type I procollagen in a form of osteogenesis imperfecta. Proc Natl Acad Sci USA. 1981;78(8):5142–6.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Orgel JP, Irving TC, Miller A, Wess TJ. Microfibrillar structure of type I collagen in situ. Proc Natl Acad Sci USA. 2006;103(24):9001–5.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Chen P, Tan Z, Shek HT, et al. Phenotypic spectrum and molecular basis in a Chinese cohort of osteogenesis imperfecta with mutations in type I collagen. Front Genet. 2022;13: 816078.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Willing MC, Deschenes SP, Slayton RL, Roberts EJ. Premature chain termination is a unifying mechanism for COL1A1 null alleles in osteogenesis imperfecta type I cell strains. Am J Hum Genet. 1996;59(4):799–809.

CAS  PubMed  PubMed Central  Google Scholar 

Chesnutt BM, Yuan Y, Buddington K, Haggard WO, Bumgardner JD. Composite chitosan/nano-hydroxyapatite scaffolds induce osteocalcin production by osteoblasts in vitro and support bone formation in vivo. Tissue Eng Part A. 2009;15(9):2571–9.

Article  CAS  PubMed  Google Scholar